Indian stocks: Visit www.stage2stocks.com →

PolyPid Ltd.

Stage 2 · Advancing · week 8

As of Oct 22, 2026, PolyPid is in Stage 2, the uptrend phase, now in week 8 (since Aug 27, 2026). It closed at $5.13, 8.1% below its 52-week high and above its 200-day average, which is rising.

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to a… More about the company

$5.13
+2.60% today
$104M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 110 in Biotechnology · #1 of 272 in Health Care

Is PYPD early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 20w
S4 63w
S2 21w
S2 13w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 20w → S1 12w → S4 63w → S1 4w → S2 10w → S3 7w → S2 21w → S3 5w → S2 13w → S3 2w → S2 8w current
Total tracked: 166 weeks across 11 stage runs.

PYPD among Biotechnology78th of 591 by relative strength

All 591 →
Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#StockStageRS1M
1GTBPStage 2 · wk 799−22.3%
2IOVAStage 2 · wk 1899+38.8%
3SLSStage 3 · wk 499−1.5%
4MRNAStage 2 · wk 1799+11.3%
5TWSTStage 2 · wk 3999−14.5%
6KODStage 2 · wk 499+172.1%
7ERASStage 3 · wk 599+0.7%
8CLYMStage 3 · wk 399−15.8%
…78PYPDStage 2 · wk 889−2.7%
vs 52W High
-8.1%
$3.18 lo$5.58 hi
8.1% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 8
1w13w26w
Week 8, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
9.2%
200 DMA: $4.70 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.44x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-2.7%
3M
+31.5%
6M
+10.6%
YTD
+17.9%
1Y
+59.3%
Scan Membership
Breakout Watch
Latest: 2022-09-01
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 8 · Vol 1.44x
2026-10-21S2
Wk 8 · Vol 1.26x
2026-10-20S2
Wk 8 · Vol 0.98x
2026-10-19S2
Wk 8 · Vol 0.99x
2026-10-16S2
Wk 8 · Vol 1.35x
2026-10-15S2
Wk 7 · Vol 1.08x
2026-10-14S2
Wk 7 · Vol 1.18x
2026-10-13S2
Wk 7 · Vol 0.80x
2026-10-12S2
Wk 7 · Vol 0.66x
2026-10-09S2
Wk 7 · Vol 0.51x
2026-10-08S2
Wk 6 · Vol 0.71x
2026-10-07S2
Wk 6 · Vol 0.90x
Moving averages & range
50 DMA
$5.11
200 DMA
$4.70
52W High
$5.58
52W Low
$3.18
5D Low
$4.72
Resistance levels (recent highs)
20d High
$5.37
60d High
$5.45
120d High
$5.58
250d High
$5.58
Next resistance
+4.7%
to 20d High
ROE
-243.6%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 19.4

PolyPid: quick answers

What stage is PolyPid in?

As of Oct 22, 2026, PolyPid (PYPD) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 27, 2026 and is in week 8. What the four stages mean

Is PolyPid in an uptrend?

Yes. PolyPid is in a Stage 2 uptrend. It trades 9.2% above its 200-day average, which is rising.

How far is PolyPid from its 52-week high?

PolyPid closed at $5.13 on Oct 22, 2026, 8.1% below its 52-week high of $5.58. Its 52-week low is $3.18.

How has PolyPid performed over the past year?

As of Oct 22, 2026, PolyPid is up 59.3% over the past year and up 17.9% so far in 2026.

Which sector and industry is PolyPid in?

PolyPid is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.